Deputy Chief Medical Officer Nick Coatsworth said the delay did not necessarily mean the vaccine deal was dead but the adverse reaction needed to be investigated.
The news site STAT first reported the pause in testing, saying the possible side effect occurred in the United Kingdom.
Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. Two other vaccines are in huge, final-stage tests in the United States, one made by Moderna Inc and the other by Pfizer and Germany's BioNTech.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Reports of adverse reaction to Oxford COVID-19 vaccineJUST IN: Deputy Chief Medical Officer Nick Coatsworth said reports the Oxford University COVID-19 vaccine had recorded a major setback in trials needed to be investigated. 9News
Read more »
Oxford coronavirus vaccine trial on hold over 'potentially unexplained illness'The Oxford University coronavirus vaccine trial is halted in what drug maker AstraZeneca describes as a 'routine' action taken when there is a potentially unexplained illness among participants.
Read more »
Reports of adverse reaction to Oxford COVID-19 vaccineJUST IN: Deputy Chief Medical Officer Nick Coatsworth said reports the Oxford University COVID-19 vaccine had recorded a major setback in trials needed to be investigated. 9News
Read more »
Vaccine experts 'surprised' over Government's 'optimistic' COVID-19 rollout timelineAs the Government announces when it expects a COVID-19 vaccine will be available to Australians, experts warn we still do not know enough to rely on the estimate.
Read more »
Union slams proposal to test for COVID-19 in pharmaciesSome pharmaceutical unions believe testing in pharmacies will put the elderly, employees and the general public at risk. Do you think COVID-19 testing should be allowed in pharmacies? 9News
Read more »
CSL deals could see COVID-19 vaccine release by early next yearThe Australian government will fund CSL to help get its facilities ready to make the University of Oxford's coronavirus vaccine onshore if successful, after the company inked deals to make more than 80 million vaccine doses | MsEmmaK
Read more »